513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection

BACKGROUND: Antimicrobial stewardship programs (ASP) have been essential during the coronavirus disease 2019 (COVID-19) pandemic response. Use of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has proven difficult to operationalize, despite being ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrantes-Figueiredo, Jessica, Nalewyko, Stephanie, Wiskirchen, Dora E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644493/
http://dx.doi.org/10.1093/ofid/ofab466.712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644493/
http://dx.doi.org/10.1093/ofid/ofab466.712

Ejemplares similares